We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Meridian Laboratories, Inc., a Buffalo, IL based specialty-oncology drug development company, has entered into a definitive agreement with Apobiologix, a part of the Apotex Inc. group, to develop and market a one-vial liquid improved formulation of doceta